Product information
From Health Canada
Current status:
Dormant
Current status date:
2019-08-01
Original market date: See footnote 1
1998-10-27
Product name:
FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP
DIN:
02237775 Electronic product monograph is not available
Company:
BAUSCH & LOMB INC
1400 N Goodman Street
Rochester
New York
United States
14609
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
36:58.00 , 52:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01JA51 FLUORESCEIN, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0207547001
Active ingredient(s) | Strength |
---|---|
BENOXINATE HYDROCHLORIDE | 0.4 % |
FLUORESCEIN SODIUM | 0.25 % |